- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Cornerstone Therapeutics Inc+ Add to Watchlist
CRTX:US9.5100 USD 0.0100 0.11%
As of 20:10:00 ET on 12/06/2013.
Company Profile for Cornerstone Therapeutics Inc (CRTX)
Cornerstone Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutic products. The Company develops products that are designed to regulate the body's inflammatory response associated with asthma and critical care diseases, and products for the respiratory market.
Cornerstone Therapeutics Inc
Key Executives for Cornerstone Therapeutics Inc (CRTX)
|Craig A CollardChairman/CEO/Founder||Kenneth R McBean "Ken"President|
|Alastair S McEwanCFO/Treasurer/Secretary||Joshua B Franklin "Josh"VP:Strategy/Investor Relations|
|Alan T RobertsVP:Scientific Affairs||Andreas MaetzelVP:Clinical & Regulatory|